Hormonal induction of transfected genes depends on DNA topology.
Plasmids containing the hormone regulatory element of mouse mammary tumor virus linked to the thymidine kinase promoter of herpes simplex virus and the reporter gene chloramphenicol acetyltransferase of Escherichia coli respond to glucocorticoids and progestins when transfected into appropriate cells. In the human mammary tumor cell line T47D, the response to progestins, but not to glucocorticoids, is highly dependent on the topology of the transfected DNA. Although negatively supercoiled plasmids respond optimally to the synthetic progestin R5020, their linearized counterparts exhibit markedly reduced progestin inducibility. This is not due to changes in the efficiency of DNA transfection, since the amount of DNA incorporated into the cell nucleus is not significantly dependent on the initial topology of the plasmids. In contrast, cotransfection experiments with glucocorticoid receptor cDNA in the same cell line show no significant influence of DNA topology on induction by dexamethasone. A similar result was obtained with fibroblasts that contain endogenous glucocorticoid receptors. When the distance between receptor-binding sites or between the binding sites and the promoter was increased, the dependence of progestin induction on DNA topology was more pronounced. In contrast to the original plasmid, these constructs also revealed a similar topological dependence for induction by glucocorticoids. The differential influence of DNA topology is not due to differences in the affinity of the two hormone receptors for DNA of various topologies, but probably reflects an influence of DNA topology on the interaction between different DNA-bound receptor molecules and between receptors and other transcription factors.
Piña
B
B
Institut für Molekularbiologie und Tumorforschung, Philipps Universität, Marburg, Federal Republic of Germany.
Haché
R J
RJ
Arnemann
J
J
Chalepakis
G
G
Slater
E P
EP
Beato
M
M
D000818:Animals; D001483:Base Sequence; D002460:Cell Line; D015500:Chloramphenicol O-Acetyltransferase / Q000235:genetics; D004247:DNA / Q000187:drug effects / Q000235:genetics / Q000648:ultrastructure; D004278:DNA, Superhelical / Q000187:drug effects; D003907:Dexamethasone / Q000494:pharmacology*; D004926:Escherichia coli / Q000235:genetics; D005798:Genes, Bacterial; D005809:Genes, Regulator / Q000187:drug effects*; D005814:Genes, Viral; D008325:Mammary Neoplasms, Experimental; D008324:Mammary Tumor Virus, Mouse / Q000235:genetics*; D051379:Mice; D008969:Molecular Sequence Data; D009649:Norpregnadienes / Q000494:pharmacology*; D015345:Oligonucleotide Probes; D010957:Plasmids / Q000187:drug effects*; D011397:Promegestone / Q000494:pharmacology*; D018139:Simplexvirus / Q000201:enzymology / Q000235:genetics*; D014162:Transfection; D015678:Viral Structural Proteins / Q000235:genetics*
D004278:DNA, Superhelical; D009649:Norpregnadienes; D015345:Oligonucleotide Probes; D015678:Viral Structural Proteins; D003907:Dexamethasone; D004247:DNA; D011397:Promegestone; D015500:Chloramphenicol O-Acetyltransferase